middle.news
Orthocell Accelerates Global Reach with Early Hong Kong Approval for Remplir™
2:47am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Orthocell Accelerates Global Reach with Early Hong Kong Approval for Remplir™
2:47am on Monday 2nd of June, 2025 AEST
Key Points
Remplir™ approved for sale in Hong Kong one month after submission
Approval accelerates Orthocell’s Asia-Pacific and North American market expansion
Total addressable market for Remplir™ exceeds US$3.5 billion across key jurisdictions
Orthocell to leverage specialist distributors for incremental markets like Hong Kong
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE